Asia Pacific Newborn Screening Market Is Growing with Increasing Incidence of Neonatal Diseases | Medtronic plc, Agilent Technologies, Waters Technologies Corporation

Overview:

Newborn screening is a program that identifies babies at risk of having rare, but serious medical conditions that can affect normal development. It is preventative public health initiative which allows detection of disorders early in life before clinical features are present. The purpose of newborn screening is to detect potentially fatal or disabling conditions in newborns as early as possible. Newborn screening tests look for developmental, genetic, and metabolic disorders in the newborn baby.

Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2546

Drivers:

Government initiatives to create awareness about newborn screening and increasing awareness among people about newborn are expected to augment the growth of the Asia Pacific newborn screening market over the forecast period. For instance, the World Health Organization (WHO) recommend newborn screening program to safeguard the health of children around the world. Numerous initiatives/policies have taken by the U.S. Department of Health, Human Services Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children and advocacy groups such as UK (PEACH) and Japan’s Society of Obstetrics and Gynecology.

Moreover, WHO is focusing on the allocation of essential resources in the form of an additional investment of US$ 0.20 cents per capita, which could save two out of every three newborns in low- and middle-income countries by 2030.

Regional Insights:

Asia Pacific, South America, and Africa are expected to witness substantial growth in the Asia Pacific newborn screening market due to the relatively high birth rates, development of novel newborn screening methodology, and improved healthcare infrastructure in these regions. For instance, in November 2018, GE Healthcare and Beyond Zero Initiative teamed up to improve access to quality and affordable primary healthcare services in Kisumu County, Kenya.

Competitive landscape:

Major players active in the Asia Pacific newborn screening market are ZenTech S.A., GE Life Sciences, Natus Medical Inc., Masimo Corporation, PerkinElmer Inc., Covidien PLC, Bio-Rad Laboratories, AB SCIEX, Agilent Technologies, Medtronic plc, Trivitron Healthcare Pvt. Ltd., and Waters Technologies Corporation, among others.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2546

The Study Objectives are:

✔ A comprehensive insight into key players operating in the Asia Pacific Newborn Screening Market and their corresponding data.
✔ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Asia Pacific Newborn Screening Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Asia Pacific Newborn Screening Industry Impact

Chapter 2 Asia Pacific Newborn Screening Competition by Types, Applications, and Top Regions and Countries
2.1 Asia Pacific Newborn Screening (Volume and Value) by Type
2.3 Asia Pacific Newborn Screening (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Asia Pacific Newborn Screening Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 Company Profiles and Key Figures in Asia Pacific Newborn Screening Business
Chapter 6 Asia Pacific Newborn Screening Market Forecast (2022-2028)
Chapter 7 Conclusions
Research Methodology